CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 164 filers reported holding CLOVIS ONCOLOGY INC in Q4 2020. The put-call ratio across all filers is 1.33 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $87,000 | +47.5% | 12,322 | 0.0% | 0.01% | +33.3% |
| Q4 2020 | $59,000 | -18.1% | 12,322 | 0.0% | 0.01% | -18.2% |
| Q3 2020 | $72,000 | -13.3% | 12,322 | 0.0% | 0.01% | -21.4% |
| Q2 2020 | $83,000 | +6.4% | 12,322 | 0.0% | 0.01% | 0.0% |
| Q1 2020 | $78,000 | -39.1% | 12,322 | 0.0% | 0.01% | -17.6% |
| Q4 2019 | $128,000 | -84.4% | 12,322 | -94.1% | 0.02% | -85.6% |
| Q3 2019 | $818,000 | +67.3% | 208,093 | +717.4% | 0.12% | +84.4% |
| Q1 2016 | $489,000 | -44.6% | 25,459 | +1.0% | 0.06% | -56.5% |
| Q4 2015 | $882,000 | – | 25,209 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 3,997,826 | $10,834,000 | 0.69% |
| Ikarian Capital, LLC | 1,112,669 | $3,016,000 | 0.45% |
| Versant Venture Management, LLC | 101,855 | $276,000 | 0.15% |
| Virtus ETF Advisers LLC | 60,836 | $165,000 | 0.06% |
| EMFO, LLC | 21,500 | $58,000 | 0.05% |
| QVT Financial LP | 505,000 | $1,369,000 | 0.05% |
| QVT Financial LP | 505,000 | $1,369,000 | 0.05% |
| PINNACLE ASSOCIATES LTD | 706,336 | $1,914,000 | 0.03% |
| XTX Topco Ltd | 20,920 | $57,000 | 0.03% |
| State of Wyoming | 25,419 | $69,000 | 0.03% |